As of 2024-12-11, the Intrinsic Value of InDex Pharmaceuticals Holding AB (INDEX.ST) is
360.24 SEK. This INDEX.ST valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y).
With the current market price of 45.30 SEK, the upside of InDex Pharmaceuticals Holding AB is
695.20%.
The range of the Intrinsic Value is 39.04 - 717.04 SEK
360.24 SEK
Intrinsic Value
INDEX.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(10,941.09) - (1,439.70) |
(2,426.12) |
-5455.7% |
| DCF (Growth 10y) |
(841.42) - (4,756.75) |
(1,252.33) |
-2864.5% |
| DCF (EBITDA 5y) |
39.04 - 717.04 |
360.24 |
695.2% |
| DCF (EBITDA 10y) |
(12.08) - 842.93 |
378.24 |
735.0% |
| Fair Value |
-0.53 - -0.53 |
-0.53 |
-101.17% |
| P/E |
(189.58) - (232.96) |
(226.29) |
-599.5% |
| EV/EBITDA |
2.73 - 170.77 |
53.34 |
17.8% |
| EPV |
(142.36) - (200.38) |
(171.37) |
-478.3% |
| DDM - Stable |
(179.14) - (1,937.05) |
(1,058.09) |
-2435.7% |
| DDM - Multi |
(193.09) - (1,619.72) |
(344.73) |
-861.0% |
INDEX.ST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
245.35 |
| Beta |
-0.92 |
| Outstanding shares (mil) |
5.42 |
| Enterprise Value (mil) |
-22.42 |
| Market risk premium |
5.10% |
| Cost of Equity |
6.25% |
| Cost of Debt |
5.00% |
| WACC |
6.22% |